These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 21940324)

  • 1. Effects of proton pump inhibitors in patients with laryngopharyngeal reflux disease.
    Chiba T; Kudara N; Abiko Y; Endo M; Suzuki K; Sugai T; Ishijima K; Fukuda K; Yamazaki K; Sato H
    Hepatogastroenterology; 2011; 58(110-111):1580-2. PubMed ID: 21940324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of age on treatment with proton pump inhibitors in patients with laryngopharyngeal reflux disease: a prospective multicenter study.
    Lee YC; Lee JS; Kim SW; Kwon KH; Eun YG
    JAMA Otolaryngol Head Neck Surg; 2013 Dec; 139(12):1291-5. PubMed ID: 24201320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical symptoms of FSSG in gastroesophageal reflux disease are critical for PPI treatment: Japanese multi-centers with 185 patients.
    Komatsu-Tanaka M; Iwakiri R; Fujimoto K; Fujiwara Y; Inamori M; Tanaka J; Shimatani T; Akiyama J; Ando T; Manabe N; Kinjo F; Deguchi R; Kusano M
    Dig Endosc; 2012 Nov; 24(6):407-11. PubMed ID: 23078431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rabeprazole is effective in treating laryngopharyngeal reflux in a randomized placebo-controlled trial.
    Lam PK; Ng ML; Cheung TK; Wong BY; Tan VP; Fong DY; Wei WI; Wong BC
    Clin Gastroenterol Hepatol; 2010 Sep; 8(9):770-6. PubMed ID: 20303417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. pH Impedance and high-resolution manometry in laryngopharyngeal reflux disease high-dose proton pump inhibitor failures.
    Carroll TL; Fedore LW; Aldahlawi MM
    Laryngoscope; 2012 Nov; 122(11):2473-81. PubMed ID: 22965767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of itopride hydrochloride and ranitidine in patients with functional dyspepsia: comparison between prokinetic and acid suppression therapies.
    Chiba T; Tokunaga Y; Ikeda K; Takagi R; Chishima R; Terui T; Kudara N; Endo M; Inomata M; Orii S; Suzuki K
    Hepatogastroenterology; 2007 Sep; 54(78):1878-81. PubMed ID: 18019739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in the quality of life of patients with laryngopharyngeal reflux after treatment.
    Lee JS; Lee YC; Kim SW; Kwon KH; Eun YG
    J Voice; 2014 Jul; 28(4):487-91. PubMed ID: 24598356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Esophageal motor dysfunction plays a key role in GERD with globus sensation--analysis of factors promoting resistance to PPI therapy.
    Tsutsui H; Manabe N; Uno M; Imamura H; Kamada T; Kusunoki H; Shiotani A; Hata J; Harada T; Haruma K
    Scand J Gastroenterol; 2012 Sep; 47(8-9):893-9. PubMed ID: 22594305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of lifestyle modification on the health-related quality of life of patients with reflux esophagitis receiving treatment with a proton pump inhibitor.
    Kinoshita Y; Ashida K; Miwa H; Hongo M
    Am J Gastroenterol; 2009 May; 104(5):1106-11. PubMed ID: 19337239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of treatment for gastro-oesophageal reflux disease with a proton pump inhibitor, and relationship between gastro-oesophageal reflux disease and Helicobacter pylori infection in Japan.
    Muramatsu A; Azuma T; Okajima T; Ohtani M; Dojo M; Yamazaki Y; Kuriyama M
    Aliment Pharmacol Ther; 2004 Jul; 20 Suppl 1():102-6. PubMed ID: 15298614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Response to gastroesophageal reflux disease therapy: assessment at 4 weeks predicts response/non-response at 8 weeks.
    Kusano M; Hongo M; Miwa H
    Digestion; 2012; 85(4):282-7. PubMed ID: 22538343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sleep disturbances and refractory gastroesophageal reflux disease symptoms in patients receiving once-daily proton pump inhibitors and efficacy of twice-daily rabeprazole treatment.
    Fujiwara Y; Habu Y; Ashida K; Kusano M; Higuchi K; Arakawa T
    Digestion; 2013; 88(3):145-52. PubMed ID: 24008338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequency scale for symptoms of gastroesophageal reflux disease predicts the need for addition of prokinetics to proton pump inhibitor therapy.
    Miyamoto M; Haruma K; Takeuchi K; Kuwabara M
    J Gastroenterol Hepatol; 2008 May; 23(5):746-51. PubMed ID: 18028348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of response to short-term proton pump inhibitor treatment in laryngopharyngeal reflux patients.
    Siupsinskiene N; Adamonis K; Toohill RJ; Sereika R
    J Laryngol Otol; 2008 Nov; 122(11):1206-12. PubMed ID: 18331659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of super high dose proton pump inhibitor administration in refractory laryngopharyngeal reflux: a pilot study.
    Portnoy JE; Gregory ND; Cerulli CE; Hawkshaw MJ; Lurie D; Katz PO; Sataloff RT
    J Voice; 2014 May; 28(3):369-77. PubMed ID: 24495427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does laparoscopic antireflux surgery improve quality of life in patients whose gastro-oesophageal reflux disease is well controlled with medical therapy?
    Gillies RS; Stratford JM; Booth MI; Dehn TC
    Eur J Gastroenterol Hepatol; 2008 May; 20(5):430-5. PubMed ID: 18403945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An Open Label, Prospective, Single Centre Study to Evaluate the Efficacy and Safety of Fixed Dose Combination of Rabeprazole (Enteric-Coated, EC) 20 mg + Domperidone (Sustained Release, SR) 30 mg Capsule in Treatment of Patients with Laryngopharyngeal Reflux Disease.
    Semmanaselvan K; Mukaddam QI; Naik M
    J Assoc Physicians India; 2015 Jul; 63(7):27-32. PubMed ID: 26731824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reflux symptom index and reflux finding score in otolaryngologic practice.
    Habermann W; Schmid C; Neumann K; Devaney T; Hammer HF
    J Voice; 2012 May; 26(3):e123-7. PubMed ID: 21477986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Weaning of proton pump inhibitors in patients with suspected laryngopharyngeal reflux disease.
    Lin RJ; Sridharan S; Smith LJ; Young VN; Rosen CA
    Laryngoscope; 2018 Jan; 128(1):133-137. PubMed ID: 28730666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of postnasal drip with proton pump inhibitors: a prospective, randomized, placebo-controlled study.
    Pawar S; Lim HJ; Gill M; Smith TL; Merati A; Toohill RJ; Loehrl TA
    Am J Rhinol; 2007; 21(6):695-701. PubMed ID: 18201449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.